David V. Goeddel's Insider Trades & SAST Disclosures
David V. Goeddel's most recent trade in Tenaya Therapeutics Inc was a trade of 35,714,284 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on March 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David V. Goeddel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 05 Mar 2025 | 35,714,284 | 49,313,559 | - | 0.7 | 24,999,999 | Common Stock |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Mar 2025 | 35,714,284 | 35,714,284 | - | - | Series A Warrant (right to buy) | |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Mar 2025 | 17,857,142 | 17,857,142 | - | - | Series B Warrant (right to buy) | |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | V. Goeddel David | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.50 per share. | 12 Feb 2024 | 2,222,222 | 13,599,275 | - | 4.5 | 9,999,999 | Common Stock |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 10 Mar 2023 | 6,779 | 11,377,053 | - | 2.6 | 17,596 | Common Stock |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 08 Feb 2023 | 1,500,000 | 11,370,274 | - | 2.6 | 3,900,000 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 30 Jan 2023 | 176,730 | 927,231 (1%) | 0% | 5.0 | 883,403 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 30 Jan 2023 | 7,542 | 750,501 (1%) | 0% | 5.0 | 37,707 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 23 Jan 2023 | 9,900 | 742,959 (1%) | 0% | 5.0 | 49,494 | Common Stock |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 19 Jan 2023 | 69,739 | 9,870,274 | - | 2.5 | 174,201 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 19 Jan 2023 | 37,639 | 732,559 (1%) | 0% | 5.0 | 188,105 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 19 Jan 2023 | 500 | 733,059 (1%) | 0% | 5.0 | 2,498 | Common Stock |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.52 per share. | 17 Jan 2023 | 135,688 | 9,800,535 | - | 2.5 | 341,432 | Common Stock |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.49 per share. | 17 Jan 2023 | 49,463 | 9,664,847 | - | 2.5 | 123,395 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.95 per share. | 12 Jan 2023 | 5,378 | 694,920 (1%) | 0% | 4.9 | 26,603 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.76 per share. | 10 Jan 2023 | 209,000 | 689,542 (1%) | 0% | 4.8 | 994,840 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.84 per share. | 10 Jan 2023 | 100,070 | 480,542 (0%) | 0% | 4.8 | 484,519 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.98 per share. | 12 Dec 2022 | 300 | 380,472 (0%) | 0% | 5.0 | 1,493 | Common Stock |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 21 Nov 2022 | 9,615,384 | 9,615,384 | - | 2.6 | 24,999,998 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 21 Nov 2022 | 35,997 | 375,842 (0%) | 0% | 5.0 | 179,942 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 21 Nov 2022 | 4,330 | 380,172 (0%) | 0% | 5.0 | 21,646 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.99 per share. | 03 Nov 2022 | 104,090 | 304,787 (0%) | 0% | 5.0 | 519,107 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.72 per share. | 03 Nov 2022 | 35,058 | 339,845 (0%) | 0% | 4.7 | 165,320 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.86 per share. | 27 Oct 2022 | 76,877 | 200,697 (0%) | 0% | 4.9 | 373,638 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.85 per share. | 25 Oct 2022 | 72,774 | 123,820 (0%) | 0% | 4.9 | 353,041 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 25 Oct 2022 | 51,046 | 51,046 (0%) | 0% | 4.7 | 242,387 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.79 per share. | 17 Oct 2022 | 80,000 | 190,000 (0%) | 0% | 3.8 | 303,256 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.18 per share. | 17 Oct 2022 | 50,000 | 130,000 (0%) | 0% | 3.2 | 159,140 | Common Stock |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.50 per share. | 09 Jun 2022 | 951,684 | 2,650,177 (3%) | 1% | 13.5 | 12,847,734 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.50 per share. | 09 Jun 2022 | 32,477 | 90,442 (0%) | 0% | 13.5 | 438,440 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.03 per share. | 02 Jun 2022 | 33,071 | 1,698,493 (2%) | 0% | 13.0 | 431,024 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.03 per share. | 02 Jun 2022 | 1,129 | 57,965 (0%) | 0% | 13.0 | 14,715 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.45 per share. | 31 May 2022 | 88,964 | 1,665,422 (2%) | 0% | 13.5 | 1,196,566 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.47 per share. | 31 May 2022 | 59,766 | 1,576,458 (2%) | 0% | 13.5 | 804,797 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.45 per share. | 31 May 2022 | 3,036 | 56,836 (0%) | 0% | 13.4 | 40,834 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.47 per share. | 31 May 2022 | 2,040 | 53,800 (0%) | 0% | 13.5 | 27,470 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.49 per share. | 26 May 2022 | 19,534 | 1,514,071 (2%) | 0% | 13.5 | 263,582 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.45 per share. | 26 May 2022 | 2,621 | 1,516,692 (2%) | 0% | 13.5 | 35,256 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.49 per share. | 26 May 2022 | 667 | 51,671 (0%) | 0% | 13.5 | 9,000 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.45 per share. | 26 May 2022 | 89 | 51,760 (0%) | 0% | 13.4 | 1,197 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.43 per share. | 24 May 2022 | 41,863 | 1,494,537 (2%) | 0% | 13.4 | 562,425 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.37 per share. | 24 May 2022 | 17,240 | 1,452,674 (2%) | 0% | 13.4 | 230,464 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.43 per share. | 24 May 2022 | 1,429 | 51,004 (0%) | 0% | 13.4 | 19,198 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.37 per share. | 24 May 2022 | 588 | 49,575 (0%) | 0% | 13.4 | 7,860 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.25 per share. | 19 May 2022 | 19,984 | 1,417,028 (2%) | 0% | 13.3 | 264,882 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.48 per share. | 19 May 2022 | 18,406 | 1,435,434 (2%) | 0% | 13.5 | 248,069 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.26 per share. | 19 May 2022 | 682 | 48,359 (0%) | 0% | 13.3 | 9,040 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.48 per share. | 19 May 2022 | 628 | 48,987 (0%) | 0% | 13.5 | 8,464 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 24,222 | 24,222 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.42 per share. | 17 May 2022 | 86,110 | 1,336,461 (2%) | 0% | 13.4 | 1,155,346 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.20 per share. | 17 May 2022 | 60,583 | 1,397,044 (2%) | 0% | 13.2 | 799,932 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.42 per share. | 17 May 2022 | 2,939 | 45,610 (0%) | 0% | 13.4 | 39,433 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.20 per share. | 17 May 2022 | 2,067 | 47,677 (0%) | 0% | 13.2 | 27,292 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 May 2022 | 125,096 | 1,218,279 (1%) | 0% | - | Common Stock | |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.90 per share. | 13 May 2022 | 32,072 | 1,250,351 (1%) | 0% | 12.9 | 413,777 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 May 2022 | 4,269 | 41,577 (0%) | 0% | - | Common Stock | |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.90 per share. | 13 May 2022 | 1,094 | 42,671 (0%) | 0% | 12.9 | 14,114 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.62 per share. | 11 May 2022 | 79,945 | 1,092,698 (1%) | 0% | 11.6 | 929,049 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.23 per share. | 11 May 2022 | 77,866 | 1,010,189 (1%) | 0% | 11.2 | 874,108 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.62 per share. | 11 May 2022 | 2,728 | 37,291 (0%) | 0% | 11.6 | 31,702 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.23 per share. | 11 May 2022 | 2,657 | 34,475 (0%) | 0% | 11.2 | 29,827 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.85 per share. | 11 May 2022 | 2,564 | 1,012,753 (1%) | 0% | 11.8 | 30,376 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.81 per share. | 11 May 2022 | 485 | 1,093,183 (1%) | 0% | 11.8 | 5,726 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.85 per share. | 11 May 2022 | 88 | 34,563 (0%) | 0% | 11.9 | 1,043 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.82 per share. | 11 May 2022 | 17 | 37,308 (0%) | 0% | 11.8 | 201 | Common Stock |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jan 2022 | 579,910 | 821,660 (1%) | 0% | - | Common Stock | |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jan 2022 | 241,750 | 241,750 (0%) | 0% | - | Common Stock | |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jan 2022 | 19,791 | 28,041 (0%) | 0% | - | Common Stock | |
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jan 2022 | 8,250 | 8,250 (0%) | 0% | - | Common Stock | |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 4,956,842 | 4,985,570 | - | 0 | Common Stock | ||
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 4,389,282 | 4,414,720 | - | 0 | Common Stock | ||
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 4,209,755 | 0 | - | - | Series A Preferred Stock | ||
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 3,727,742 | 0 | - | - | Series A Preferred Stock | ||
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 533,781 | 0 | - | - | Series B Preferred Stock | ||
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 472,659 | 0 | - | - | Series B Preferred Stock | ||
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 213,306 | 0 | - | - | Series C Preferred Stock | ||
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 188,881 | 0 | - | - | Series C Preferred Stock | ||
| Ngm Biopharmaceuticals Inc | David V. Goeddel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 19,619 | 19,619 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges